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Development of a Serological Assay for
the Sea Lion (Zalophus californianus)
Anellovirus, ZcAV
Elizabeth Fahsbender1, Karyna Rosario1, John P. Cannon2, Frances Gulland3, Larry J. Dishaw2
& Mya Breitbart1,2
1University of South Florida, College ofMarine Science, 1407th Avenue South, Saint Petersburg, FL 33701USA, 2University of South
Florida, College ofMedicine, Department of Pediatrics, 8016th Street South, Saint Petersburg, FL 33701USA, 3TheMarineMammal
Center, 2000 Bunker Road, Sausalito, CA 94965 USA.
New diseases in marine animals are emerging at an increasing rate, yet methodological limitations hinder
characterization of viral infections. Viral metagenomics is an effective method for identifying novel viruses
in diseased animals; however, determining virus pathogenesis remains a challenge. A novel anellovirus
(Zalophus californianus anellovirus, ZcAV) was recently reported in the lungs of captive California sea lions
involved in a mortality event. ZcAV was not detected by PCR in the blood of these animals, creating the
inability to assess the prevalence of ZcAV in live sea lions. This study developed an enzyme-linked
immunosorbent assay (ELISA) to detect antibodies to ZcAV in sea lion serum. To assess ZcAV prevalence,
paired serum and lung samples (n5 96) from wild sea lions that stranded along the California coast were
tested through ELISA and PCR, respectively. Over 50% of the samples tested positive for ZcAV by ELISA
(34%), PCR (29%), or both (11%) assays. ZcAV is prevalent in stranded wild sea lion populations and results
suggest that PCR assays alone may grossly underestimate ZcAV exposure. This ELISA provides a tool for
testing live sea lions for ZcAV exposure and is valuable for subsequent studies evaluating the potential
pathogenicity of this anellovirus.
T he rate of emergence of new diseases in marine animals is increasing
1–4, generating a need for surveillance of
potential pathogens to protect marine mammals against epidemics. However, it remains difficult to char-
acterize and diagnose viral infections because of methodological limitations5. Current detection methods
such as degenerate PCR and pan-viral microarrays can detect close relatives of previously described viruses, but
are limited for detecting novel viruses. Viral metagenomics (virus particle purification followed by shotgun
sequencing) is an effective method for identifying viruses involved in mortality events in marine animals6–9,
yet it remains difficult to establish a connection between a novel virus and disease due to limitations of culturing
the viruses as well as difficulties in obtaining fresh diagnostic tissues from wild marine mammals.
Viral metagenomics performed on lung tissue of several necropsied captive California sea lions (Zalophus
californianus) with signs of respiratory disease that were involved in amortality event of unknown cause revealed
the presence of a novel anellovirus, Zalophus californianus anellovirus (ZcAV)7. ZcAVwas found by specific PCR
in the lungs of all three of the sea lions that died in the mortality event, but it was not found in sea lions from the
same zoo that died of unrelated causes. In addition, ZcAV was found to be actively replicating in lung tissue of a
sea lion from the mortality event, further suggesting an association of ZcAV with the death of these animals. In
addition to the captive sea lions, 11% of lung samples from wild sea lions stranded off the California coast tested
positive for ZcAV by PCR, indicating that this anellovirus is present in wild populations.
The initial ZcAV discovery and prevalence studies have raised many questions about the potential pathogeni-
city of this virus. Anelloviruses have been extensively studied in humans, where these viruses can be highly
prevalent (infecting up to 100% of the population)10–13, yet they have not been linked to human disease. Although
anelloviruses have also been found in a wide range of mammals including non-human primates14, domestic
animals15, Pacific harbor seals9, and Risso’s dolphins (E.M. Fahsbender et al., unpublished data), anellovirus-
associated pathology remains unknown. Initial evidence suggested that ZcAV may be linked to the mortality
event of captive California sea lions; however, studies investigating the pathogenicity of this virus are difficult
since ZcAV has only been detected by PCR in tissues of necropsied animals, and cannot be detected by PCR in the
blood of infected individuals7. The inability to detect ZcAV in blood samples by PCR severely limits further
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testing for this virus, since obtaining lung biopsies from live sea lions
is not possible. Hence, there is a critical need for an assay to detect
ZcAV exposure in blood samples to investigate the epidemiology of
this virus, understand its association with disease, and preemptively
develop management strategies that can prevent the spread of this
virus in captive and rehabilitation animals. To overcome these tech-
nical limitations of studying the role of ZcAV in disease, here we
describe the development of an enzyme-linked immunosorbent
assay (ELISA) for ZcAV, and demonstrate that sea lions mount an
immune response against ZcAV.
Similar to other anelloviruses16, ZcAV contains a small (2140 nuc-
leotide (nt)), negative sense, single-stranded DNA circular genome
that encodes three major open reading frames (ORFs). Based on
similarities to other anelloviruses, ORF 1 is believed to encode the
capsid protein, although this has not been experimentally demon-
strated for any anellovirus. For other anelloviruses, the ORF 1 gene
product has been predicted to be antigenic due to the presence of
major hydrophilic regions, and ORF 1 has been successfully used in
seroprevalence studies in humans and pigs11,17–20. Here we developed
an ELISA based on hydrophilic regions of the ORF 1 gene product of
the ZcAV genome and demonstrated that this assay is capable of
detecting anti-ZcAV antibodies in sea lion serum. This ELISA pro-
vides a tool for studying ZcAV epidemiology and identifying sero-
conversion upon symptom development in captive sea lions,
enabling future research investigating the pathogenesis of ZcAV.
Finally, the creation of this assay lays the groundwork for bridging
the gap between genome discovery via viral metagenomics and asses-
sing the epidemiology of novel viruses and their significance for wild
populations.
Methods
Sample collection. Paired serum and lung samples were collected from 100
California sea lions involved in stranding events along the coast of northern
California. All samples were collected by The Marine Mammal Center located in
Sausalito, California in accordance with Marine Mammal Protection Act permit no
932-1905/MA-009526 to Gulland. Serum samples were collected during routine
clinical examinations of live stranded sea lions as described by Bossart et al.21 and
archived at 270uC. Lung samples were collected from the same animals upon
necropsy, with animals stored at 4uC between time of death and necropsy (within
24 hours of death). All protocols were approved under the Marine Mammal
Protection Act. Paired lung and serum samples were shipped to the University of
South Florida and stored at280uC for processing using PCR (for lung samples) and
ELISA (for serum samples).
PCR testing of sea lion lung samples.Lung samples were testedwith a ZcAV-specific
PCR assay. For this purpose, DNA was extracted from approximately 25 mg of sea
lion lung tissue using the DNeasy Blood and Tissue Kit (Qiagen). DNAwas amplified
through rolling circle amplification (RCA) using the Illustra Templiphi Kit (GE
Healthcare), which is known to enrich for small circular templates such as the ZcAV
genome22,23. RCA products were then used as the DNA templates for the PCR assay
using primers ZcAV1056F (59-AGG CAC TCA CAT AAT CTA TTC AA-39) and
ZcAV1369R (59-CCC AGG CAT TAC AGG CTT TA-39) designed to target a 314 nt
region from ORF 1 of ZcAV. The PCR [containing 1 mM of each primer, 200 mM of
dNTPs, 1 U of Red Taq (Sigma-Aldrich), 1X Red Taq reaction buffer and 2.5 ml of
DNA template in a 25 ml reaction] proceeded as follows: 95uC for 5minutes, 45 cycles
of [94uC for 1 minute, 54uC for 1 minute, and 72uC for 1 minute], followed by a final
extension at 72uC for 10minutes. PCR products of the correct size were verified by gel
electrophoresis. Four samples were cloned using a TOPO TA Cloning Kit
(Invitrogen) and commercially sequenced. Sequences were then compared against
the GenBank database in order to verify the specificity of the assay. To determine
assay sensitivity, a positive control was prepared as previously described. The PCR
product was cleaned using the UltraClean PCR Clean-Up Kit (Mo Bio Laboratories)
and quantified using a NanoDrop ND-1000 apparatus (NanoDrop Technologies).
The number of targets permicroliter was back-calculated and the positive control was
serially diluted to determine the sensitivity of the assay, which was 10 targets.
Optimization of ELISA parameters. An ELISA was developed to screen sea lion
serum for antibodies to ZcAV. Since the virus was identified from a mixed
community using metagenomics, there were no purified virus particles that could be
used as an antigen for the ELISA. Therefore, the ELISA was developed based on
regions predicted to be immunogenic based on hydrophilic sections found in the
predicted protein sequence of ORF 1. Four peptides (on average, 25 amino acids in
length) from different regions of ORF 1 were synthesized at 70% purity by Pacific
Immunology. Each of these peptides was scrambled, synthesized and used as a control
peptide. Sea lion sera were used as primary antibodies, while alkaline phosphatase
(AP)-conjugates of protein A (Roche) and protein L (Thermo Scientific) were used as
detection reagents. Protein A is a bacterially-derived molecule that binds to the Fc
region of IgG of many mammalian species; in contrast, protein L, also derived from
bacteria, binds to immunoglobulin light chains and thus has the ability to detect a
wider range of serum antibodies, including IgG, IgM, IgA and IgE24–26. Similar
reagents have been used previously in sea lion serological testing26. Checkerboard
titrations were performed to find optimal concentrations of peptide, serum, and
proteins. After initial screening, peptide 4T (amino acid sequence:
GMENTPPKRVRFRQSDVLRKHKHRI), along with its scrambled control peptide
4C (amino acid sequence: QRLHPKKHIRSETKFVRVDRNPGMR) were chosen as
primary targets due to their low background. Protein L was selected as the detection
reagent since it is able to bind more classes of immunoglobulins than protein A.
ELISA testing of sea lion serum samples.High binding 96-well microtiter plate wells
were coated with a final concentration of 1 mg/ml peptide diluted in 0.5 M carbonate
buffer (pH 9.6) (1.59 g of Na2CO3, 2.93 g of NaHCO3, 0.2 g of NaN3, and dH2O to 1
liter) and the plate was incubated overnight at 4uC. All wells were washed three times
with a phosphate-buffered saline (PBS) solution containing 0.1% Tween-20 (PBS-
tween) using an automatedmicrotiter plate washer, and then blocked with 1% bovine
serum albumin (BSA) diluted 155 in PBS-tween for 1 hour. Sea lion serum samples
were diluted 1550 in PBS-tween containing 1% BSA, added to each well in triplicates,
and left to incubate overnight at 4uC. The plate was then washed and blocked as
previously described before secondary reagent protein L was added in PBS-tween
containing 1% BSA at a 1510,000 dilution and left to incubate at 37uC for 1 hour.
Each well was washed as previously described. ELISA Blue (SureBlue Reserve) was
added and incubated at room temperature for 10–20 minutes. Plates were read on a
PerkinElmer Enspire machine to measure optical density (OD) at 650 nm.
Statistical Analysis. The statistical software package GraphPad Instat (GraphPad
Software, Inc.) was used to perform an analysis of variance (ANOVA) on averages of
the triplicate sea lion serum samples. Samples with p-values ,0.05 were considered
statistically significant. Samples were considered positive if serum incubated with the
test peptide (4T) had a statistically significant higher OD value than the serum
incubated with the control peptide (4C).
Results
Development of the ELISA using serum samples from sea lions
whose lung samples were PCR-positive for ZcAV demonstrated that
sea lions mount an immune response to ZcAV infection. Paired
serum and lung samples from 100 stranded California sea lions were
then tested for the presence of ZcAV nucleic acids and anti-ZcAV
antibodies through PCR and the newly developed ELISA, respect-
ively. Four samples were removed from the data set due to high
background with the ELISA. Of the 96 samples tested, 50 (52%)
tested positive for ZcAV exposure (ELISA; serum samples; n533
[34%]) and/or DNA presence (PCR; lung samples; n528 [29%])
(Table 1). Eleven percent of the sea lions tested positive for ZcAV
by both ELISA and PCR, and 48% of sea lions tested negative by both
methods. Of the 28 sea lions with PCR-positive lung samples, 39%
were also serum-positive by ELISA. However, 32% of the PCR-nega-
tive sea lions (n568) also tested positive for ZcAV exposure via
ELISA. The Kappa value of 0.066, calculated using GraphPad, indi-
cates poor correlation between the PCR and ELISA test results.
Discussion
The ELISA developed in this study provides the first and only
method to test for ZcAV exposure in live sea lions. Here, this assay
was used in combination with PCR to assess the prevalence of ZcAV
in the wild, stranded sea lion population along the northern coast of
California. Protein-L-based detection of ZcAV-specific antibodies
suggests the exposed sea lions are able to recognize and mount
immune responses to the virus. These data, which are the first
obtained for marine mammal anelloviruses, support prior studies
showing that human anelloviruses are immunogenic, with both
IgG and IgM class antibodies produced upon exposure to ORF
127,28. The combined ELISA and PCR results demonstrate that
ZcAV infections are prevalent and persistent in wild California sea
lions.
The development of this ELISA was unconventional due to the
many difficulties of working with marine mammals. Gaining access
to 100 paired serum and lung samples from a protected species is
both arduous and time consuming. Furthermore, the sea lion
www.nature.com/scientificreports
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immune system is not frequently studied; therefore, there are no
commercial antibodies for sea lions. In addition to the many ambi-
guities of the sea lion immune system, ZcAV is not a well-understood
virus. ZcAV was discovered from a mixed community and attempts
to isolate ZcAV virions in culture have been unsuccessful, limiting
sensitivity testing of this ELISA. In addition, without more know-
ledge of the types of related anelloviruses found inmarine mammals,
the specificity of this assay cannot be determined.
Although the ELISA and PCR results obtained in this study were
not correlated, the ZcAV ELISA provides complementary results to
the PCR data, providing a greater scope to measure virus prevalence,
as use of the ZcAV ELISA increased the detection of exposure to
ZcAV. There are multiple explanations for the incongruences
between the ELISA and PCR data. ELISA-positive, but PCR-negative
samples (23%) are likely due to previous ZcAV infections in which
the viral DNA is no longer present but the ELISA can detect the
presence of (long-lived) antibodies, suggesting a prior exposure.
Similar results have been seen for the human anellovirus Torque
teno virus (TTV), where antibodies were detected despite the absence
of TTV DNA11. In addition, if the ZcAV infection occurred in
another sea lion organ instead of the lungs, we could expect a
PCR-negative but ELISA-positive result. Conversely, sea lion sam-
ples may have tested positive by PCR but negative by ELISA (18%) if
the sea lions were actively infected upon stranding and died before a
detectable antibody response was mounted. Although the timing of
the response of the sea lion immune system to ZcAV is unknown,
development of the human antibody response to TTV is slow and
known to take up to 21 weeks after virus inoculation29, although once
the antibodies are produced they persist in serum for long
periods28,30. Finally, slight sequence mutations or antigenic diversity
of anelloviruses may also contribute to data incongruency.
Anelloviruses are known to demonstrate a high degree of genetic
variability19,31,32 which can pose problems for both DNA detection
by PCR primers and antibody detection. For certain TTV genotypes,
it has been shown that multiple serotypes may exist in circulation20.
Future work should compare the diversity of anelloviruses that can
be detected by the PCR and ELISA utilized in this study, as the
discrepancy between the two assay types may reflect differences in
the diversity of genotypes and serotypes recovered.
Through a combination of PCR- and ELISA-based testing, this
study demonstrated that sea lions mount an immune response to the
anellovirus ZcAV and revealed the high prevalence of ZcAV in a
strandedwild sea lion population. The ELISA created here will enable
future research on the epidemiology of ZcAV in live sea lions and
allow further study of ZcAV pathogenesis by measuring seroconver-
sion in infected captive sea lions. Finally, this assay has direct impli-
cations for protecting sea lion health since it is the only method
available for the detection of ZcAV in live sea lions. The ZcAV
ELISA enables the screening of rehabilitation animals before admit-
ting them into facilities with healthy animals, which can prevent the
spread of this virus to other captive sea lions and provide a valuable
management step if further work links ZcAV with disease.
1. Harvell, C. D. et al. Emerging marine diseases--climate links and anthropogenic
factors. Science 285, 1505–1510 (1999).
2. Gulland, F. D. & Hall, A. Is marine mammal health deteriorating? Trends in the
global reporting of marine mammal disease. EcoHealth 4, 135–150 (2007).
3. Jones, K. E. et al. Global trends in emerging infectious diseases. Nature 451,
990–993 (2008).
4. Keesing, F. et al. Impacts of biodiversity on the emergence and transmission of
infectious diseases. Nature 468, 647–652 (2010).
5. Delwart, E. L. Viral metagenomics. Rev Med Virol 17, 115–131 (2007).
6. Ng, T. F. F. et al. Discovery of a novel single-stranded DNA virus from a sea turtle
fibropapilloma by using viral metagenomics. J Virol 83, 2500–2509 (2009).
7. Ng, T. F. F., Suedmeyer, W. K., Wheeler, E., Gulland, F. & Breitbart, M. Novel
anellovirus discovered from amortality event of captive California sea lions. J Gen
Virol 90, 1256–1261 (2009).
8. Li, L. et al. The fecal viral flora of California sea lions. J Virol 85, 9909–9917 (2011).
9. Ng, T. F. F. et al. Metagenomic identification of a novel anellovirus in Pacific
harbor seal (Phoca vitulina richardsii) lung samples and its detection in samples
from multiple years. J Gen Virol 92, 1318–1323 (2011).
10. Prescott, L. E., Simmonds, P. & Collaborators & International. Global distribution
of transfusion-transmitted virus. New Engl J Med 339, 776–777 (1998).
11. Handa, A., Dickstein, B., Young, N. S. & Brown, K. E. Prevalence of the newly
described human circovirus, TTV, in United States blood donors. Transfusion 40,
245–251 (2000).
12. Biagini, P. et al. Distribution and genetic analysis of TTV and TTMV major
phylogenetic groups in French blood donors. J Med Virol 78, 298–304 (2006).
13. Okamoto, H. in TT VirusesVol. 331 Current TopMicrobiol (eds Ethel-Michele de
Villiers & Haraldzur Hausen) Ch. 1, 1–20 (Springer Berlin Heidelberg, 2009).
14. Romeo, R. et al. High prevalence of TT virus (TTV) in naive chimpanzees and in
hepatitis C virus-infected humans: frequent mixed infections and identification of
new TTV genotypes in chimpanzees. J Gen Virol 81, 1001–1007 (2000).
15. Biagini, P. et al. Circular genomes related to anelloviruses identified in human and
animal samples by using a combined rolling-circle amplification/sequence-
independent single primer amplification approach. J Gen Virol 88, 2696–2701
(2007).
16. Biagini, P. in TT Viruses Vol. 331 Current Top in Microbiol (eds Ethel-Michele
Villiers & Haraldzur Hausen) Ch. 2, 21–33 (Springer Berlin Heidelberg, 2009).
17. Huang, Y.W. et al. Expression of the putative ORF1 capsid protein of Torque teno
sus virus 2 (TTSuV2) and development of western blot and ELISA serodiagnostic
assays: Correlation between TTSuV2 viral load and IgG antibody level in pigs.
Virus Res 158, 79–88 (2011).
18. Huang, Y.-W. et al. Serological profile of torque teno sus virus species 1 (TTSuV1)
in pigs and antigenic relationships between two TTSuV1 genotypes (1a and 1b),
between two species (TTSuV1 and -2), and between porcine and human
anelloviruses. J Virol 86, 10628–10639 (2012).
19. Okamoto, H. et al. The entire nucleotide sequence of a TT virus isolate from the
United States (TUS01): Comparison with reported isolates and phylogenetic
analysis. Virology 259, 437–448 (1999).
20. Ott, C. et al. Use of a TT virus ORF1 recombinant protein to detect anti-TT virus
antibodies in human sera. J Gen Virol 81, 2949–2958 (2000).
21. Bossart, G. D., Reidarson, T. H., Dierauf, L. A. &Duffield, D. A. inCRCHandbook
of Marine Mammal Medicine 2nd edn (eds Dierauf, L.A. and Gulland, F.M.D.)
(CRC Press 2001).
22. Kim, K.-H. et al. Amplification of uncultured single-stranded DNA viruses from
rice paddy soil. Appl Environ Microbiol 74, 5975–5985 (2008).
23. Kim, K.-H. & Bae, J.-W. Amplification methods bias metagenomic libraries of
uncultured single-stranded and double-stranded DNA viruses. Appl Environ
Microbiol 77, 7663–7668 (2011).
24. Kessler, S. W. Rapid isolation of antigens from cells with a staphylococcal protein
A-antibody adsorbent: Parameters of the interaction of antibody-antigen
complexes with protein A. J Immunol 115, 1617–1624 (1975).
25. Nilson, B. H., Solomon, A., Björck, L. & Akerström, B. Protein L from
Peptostreptococcus magnus binds to the kappa light chain variable domain. J Biol
Chem 267, 2234–2239 (1992).
26. De Chateau, M. et al. On the interaction between protein L and immunoglobulins
of various mammalian species. Scand J Immunol 37, 399–405 (1993).
27. Tsuda, F. et al. Determination of antibodies to TT virus (TTV) and application to
blood donors and patients with post-transfusion non-A to G hepatitis in Japan.
J Virol Methods 77, 199–206 (1999).
28. Tsuda, F. et al. IgM-class antibodies to TT virus (TTV) in patients with acute TTV
infection. Hepatol Res 19, 1–11 (2001).
29. Tawara, A. et al. Transmission of human TT virus of genotype 1a to chimpanzees
with fecal supernatant or serum from patients with acute TTV infection. Biochem
Biophys Res Commun 278, 470–476 (2000).
Table 1 | Prevalence of ZcAV in paired serum and lung samples from a stranded wild population of California sea lions (Zalophus
californianus; n596) assessed by ELISA and PCR, respectively
Serum ELISA positive n5 (%) Serum ELISA negative n5 (%) PCR totals n5 (%)
Lung PCR positive n5 (%) 11 (11%) 17 (18%) 28 (29%)
Lung PCR negative n5 (%) 22 (23%) 46 (48%) 68 (71%)
ELISA totals n5 (%) 33 (34%) 63 (66%)
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 9637 | DOI: 10.1038/srep09637 3
30. Maggi, F. & Bendinelli, M. in TT Viruses Vol. 331 Current Top Microbiol (eds
Ethel-Michele de Villiers & Haraldzur Hausen) Ch. 5, 65–90 (Springer Berlin
Heidelberg, 2009).
31. Okamoto, H. et al. Molecular cloning and characterization of a novel DNA virus
(TTV) associated with posttransfusion hepatitis of unknown etiology.Hepatol Res
10, 1–16 (1998).
32. Hijikata, M., Takahashi, K. &Mishiro, S. Complete circular DNA genome of a TT
virus variant (isolate name SANBAN) and 44 partial ORF2 sequences implicating
a great degree of diversity beyond genotypes. Virology 260, 17–22 (1999).
Acknowledgments
This project was funded through an Interdisciplinary Research Development Grant from
the University of South Florida’s College of Marine Science. The authors thank Dr. Michael
Shamblott, Marci O’Driscoll, and Elizabeth Wheeler for guidance with experiments, use of
equipment, and feedback on the manuscript, and the staff and volunteers of The Marine
Mammal Center for care and sampling of the stranded sea lions.
Author contributions
E.F. developed the ELISA, tested samples, and wrote the manuscript. F.G. collected the sea
lion samples. K.R., M.B., J.C. and L.D. advised and aided with the development of the ELISA
and data analysis. All authors reviewed the manuscript.
Additional information
How to cite this article: Fahsbender, E. et al. Development of a Serological Assay for the Sea
Lion (Zalophus californianus) Anellovirus, ZcAV. Sci. Rep. 5, 9637; DOI:10.1038/srep09637
(2015).
This work is licensed under a Creative Commons Attribution 4.0 International
License. The images or other third party material in this article are included in the
article’s Creative Commons license, unless indicated otherwise in the credit line; if
the material is not included under the Creative Commons license, users will need
to obtain permission from the license holder in order to reproduce thematerial. To
view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 9637 | DOI: 10.1038/srep09637 4
Competing financial interests The authors declare no competing financial interests.:
